Tagged Articles

nursing homes 74 articles

Peanut factory knowingly sold salmonella-contaminated peanuts to food suppliers

The Peanut Corporation of America knowingly distributed salmonella contaminated peanuts to manufacturers and presented faked documents to back up those false claims, in what has become one of the largest salmonella outbreaks in U.S. history, according to court testimony. The trial has begun for three executives of the peanut producer over the 2009 outbreak that killed nine people and sickened at least 700 others. Peanut Corporation of America went bankrupt in 2009 after it was identified as the source of the outbreak. Then-plant manager Sammy Lightsey testified against plant owner Stewart Parnell, saying he discovered that the company was shipping peanuts on ... Read More

Jury selection begins for trial of employees of peanut processing plant at center of deadly Salmonella outbreak

Jury selection is underway for the trial of three people, employees and associates with a peanut processing plant blamed for the deadliest Salmonella outbreak in U.S. history, which killed nine people and sickened more than 700 in 2009. Former Peanut Company of America owner Stewart Parnell, his brother and food broker Michael Parnell, and the peanut plant’s quality control manager Mary Wilkerson were indicted last year on 76 criminal counts that allege the three shipped peanuts contaminated with Salmonella to industrial food customers – including nursing homes, schools and food suppliers – and covered up lab tests that showed some batches ... Read More

New study finds significant link between Depakote use and birth defects

A new study published in an international neurology journal has found “statistically significant associations” between valproate drugs such as Depakote (valproic acid) and spina bifida, as well as malformations of the heart, great vessels, digits, skull bones, and brain. The study, published March 6 in the international neurology journal Acta Neurologica Scandinavica, underscores concerns that Depakote exposure, especially in childbearing women, can interrupt fetal development and lead to a spectrum of birth defects. Another recent study, published in the Lancet Neurology journal in January, linked Depakote exposure prior to birth to lower average IQs in children. Researchers found that the higher ... Read More

Child finds Depakote, Adderall drugs inside Easter egg during church egg hunt

DAPHNE, ALA—An arrest has been made in the case of an Easter egg hunt at an Alabama Catholic Church that resulted in a child finding prescription drugs inside a plastic egg instead of candy. Authorities say that 21-year-old Jarrett Helm has been arrested and charged with disorderly conduct in connection with the incident. According to the Daphne police department, a 6-year-old child found an Easter egg that contained one Depakote pill and half an Adderall pill while searching for Easter eggs at Christ the King Catholic Church. Depakote is an antiepileptic drug that maker Abbott Laboratories has aggressively marketed for ... Read More

CDC warns of deadly ‘nightmare bacteria’

The Centers for Disease Control and Prevention (CDC) is warning hospitals and nursing homes to be on the lookout for a “nightmare bacteria” that can resist most antibiotics and kill patients. Carbapenem-resistant Enterobacteriaceae (CRE), are a family of germs that can cause infections. In the past 10 years, CREs have caused a growing number of difficult-to-treat infections in health-care settings. Even more disturbing, CRE can transfer their antibiotic resistance to other bacteria. CRE infections most commonly occur among patients in health care centers who are receiving treatment for other conditions, and is particularly dangerous to patients whose care requires devices such ... Read More

Is Abbott’s Depakote settlement an incentive to break the law?

What’s the price of defrauding state and federal healthcare systems and potentially putting thousands of patients at risk? In the case of Abbott Laboratories and its CEO, Miles D. White, it’s a slap on the wrist and a fine that represents a small percent of giant profits made by pushing a prescription drug for off-label and unapproved purposes. According to Dow Jones Newswires, the U.S. Justice Department declined to intervene in whistleblower allegations that White engaged in “unlawful conduct” and personally gained from his corporation’s illegal promotion of its anti-seizure drug Depakote. A former Abbott employee made the allegations against ... Read More

Abbott Laboratories sentenced for illegally promoting Depakote

Abbott Laboratories received a formal sentence this month for illegally promoting its anti-seizure drug Depakote for off-label and unapproved purposes – a charge to which the company pleaded guilty in May. U.S. District Court Judge Samuel Wilson of the Western District of Virginia ordered Abbot to pay $500 million in criminal fines, forfeit nearly $200 million more, and pay $1.5 million to the Virginia Medicaid Fraud Control Unit. The company was also given a five-year probation term. Corporate probation is a requirement sometimes imposed when the court finds the company lacks an effective program to detect and deter future violations ... Read More

Abbott slapped with more fines for illegal promotion of Depakote

Abbott Laboratories was fined more than $700 million for illegally promoting its anti-seizure drug Depakote for unapproved uses. The drug company was ordered to pay a fine of $500 million, forfeit another $198.5 million, and pay $1.5 million to the Virginia Medicaid Fraud Control Unit. The drug company will also be subject to a five-year probation. The fines are in addition to the $1.6 billion the company agreed to pay to settle criminal and civil claims that arose from the unlawful promotion of Depakote. Abbott admitted that from January 1998 to December 2006 it marketed Depakote as a treatment for ... Read More

Johnson and Johnson to pay up to $2.2 billion in Risperdal lawsuit

Pharmaceutical giant Johnson & Johnson has agreed to pay as much as $2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal. The lawsuit claims Johnson & Johnson paid kickbacks to a company that provided prescription drugs to nursing home patients in order to increase the sales of Risperdal, a drug approved to treat symptoms of schizophrenia and bipolar disorder. The drug has been associated with an increased risk of death in elderly people with dementia. The settlement will include a $400 million criminal fine. The final amount Johnson & Johnson pays will be determined by how many ... Read More

Rate of hospital readmissions increases for artificial hip recipients

The average length of a hospital stay for patients who have hip replacement surgery has dropped considerably in recent years, but the rate of readmissions for complications or referrals to nursing homes has increased, according to a new study. Researchers reviewed 1.5 million Medicare Part A beneficiaries who underwent primary total hip replacement surgery between 1991 and 2008, and 348,596 people who underwent revision surgery, or surgery to replace an artificial hip. The average length of hospital stay for primary hip replacement patients dropped from 9.1 days during the first two years of the study to 3.7 days during the ... Read More